Financials

18/11/2021

18/11/2021 IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction


15/11/2021

15/11/2021 Management’s Discussion and Analysis


15/11/2021

15/11/2021 IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update


30/09/2021

30/09/2021 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS


16/08/2021

MD&A – English


16/08/2021

Interim financial statements/report – English


17/05/2021

MD&A – English


17/05/2021

Interim financial statements/report – English


23/04/2021

MD&A – English


23/04/2021

Audited annual financial statements – English


01/04/2021

IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer
Subsidiary, Highland Grow


11/04/2021

IM Cannabis Provides Update on Adjupharm Business Developments in Germany


13/04/2021

Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market


30/04/2021

IM Cannabis Acquires Israel’s Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand


23/04/2021

IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook


10/05/2021

IM Cannabis Announces Closing of US$ 35 Million Equity Financing


04/05/2021

M Cannabis Announces Proposed Public Offering of Securities


05/05/2021

IM Cannabis Announces Pricing of Proposed Public Offering of Securities


18/03/2021

IMC Closes Acquisition of Trichome, Establishing Global Growth Platform in Both Adult Use and Medical Cannabis Markets


31/03/2021

IMC Announces Filing of Final Short Form Base Shelf Prospectus